文献速递消化道肿瘤放疗姑息放疗与转移瘤

碳离子放疗治疗局部复发性直肠癌:日本碳离子放射肿瘤学研究组(J-CROS)1404直肠研究

Carbon-ion radiotherapy for locally recurrent rectal cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1404 Rectum.
PubMed 文献 · Radiother Oncol · 2018-10-22

该多机构回顾性分析纳入2003年11月至2014年12月在3家机构接受碳离子放疗的224例局部复发性直肠癌患者,处方剂量为70.4 Gy(RBE)或73.6 Gy(RBE)分16次。中位随访62个月,3年总生存率73%、5年51%,3年局部控制率93%、5年88%,3级急性毒性3例、3级晚期毒性12例,无4级或5级毒性。作者认为结局相对良好且毒性有限。

要点

  • 224例局部复发性直肠癌接受碳离子放疗,处方剂量70.4 Gy(RBE)或73.6 Gy(RBE)分16次。
  • 3年总生存率73%、5年51%;3年局部控制率93%、5年88%。
  • 3级急性毒性3例、3级晚期毒性12例,无4级或5级急晚期毒性。

核心结论

  • 作者认为,这是针对局部复发性直肠癌碳离子放疗的首个多机构分析,显示结局相对良好且毒性有限。

研究设计与样本

  • 回顾性分析2003年11月至2014年12月在3家机构接受碳离子放疗的局部复发性直肠癌患者数据,共收集224例患者数据。
  • 研究终点为总生存、局部控制及急性/晚期毒性。

主要发现

  • 处方剂量为70.4 Gy(RBE)或73.6 Gy(RBE)分16次,自碳离子放疗开始的中位随访期为62个月(范围6-169个月)。
  • 总生存率3年为73%(95%CI 67%-79%),5年为51%(95%CI 44%-58%)。
  • 局部控制率3年为93%(95%CI 88%-96%),5年为88%(95%CI 82%-93%)。
  • 3级急性毒性3例:胃肠道毒性1例、盆腔感染2例。
  • 3级晚期毒性12例:皮肤反应2例、胃肠道毒性2例、神经病变1例、盆腔感染7例;无4级或5级急性或晚期毒性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated the efficacy and safety of carbon-ion radiotherapy (C-ion RT) for locally recurrent rectal cancer (LRRC). PATIENTS AND METHODS: Data from patients with LRRC treated with C-ion RT from November 2003 to December 2014 at three institutions were retrospectively analyzed. The endpoints of this clinical trial were overall survival (OS), local control (LC), and acute/late toxicity. RESULTS: A total of 224 patients' data were collected. The prescribed dose was 70.4 Gy (relative biological effectiveness [RBE]-weighted absorbed dose) or 73.6 Gy (RBE) in 16 fractions. The median follow-up period from the initiation of C-ion RT was 62 months (range 6-169 months). The OS rates were 73% (95% confidence interval [CI], 67%-79%) at 3 years and 51% (95%CI 44%-58%) at 5 years. The LC rates were 93% (95%CI 88%-96%) at 3 years, and 88% (95%CI 82%-93%) at 5 years. Grade 3 acute toxicity was observed in three patients: gastrointestinal toxicity (n = 1) and pelvic infection (n = 2). Grade 3 late toxicity was observed in 12 patients: skin reaction (n = 2), gastrointestinal toxicity (n = 2), neuropathy (n = 1), and pelvic infection (n = 7). There was no grade 4 or 5 acute or late toxicity. CONCLUSIONS: This first multi-institutional analysis of C-ion RT for LRRC indicated relatively favorable outcomes with limited toxicities.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Shinoto M, Yamada S, Okamoto M, et al. Carbon-ion radiotherapy for locally recurrent rectal cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1404 Rectum. Radiother Oncol. 2018. PMID: 30360998. doi:10.1016/j.radonc.2018.10.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。